TELA Bio, Inc. announces corporate restructuring and executive leadership changes

TELA Bio, Inc. filed an 8-K disclosing cost-cutting measures related to exit or disposal activities alongside changes to its executive leadership and board composition. The filing indicates a material shift in operational strategy, though specific financial impacts and the identities of departing officers remain to be detailed in subsequent disclosures.